Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7Urinary Bladder Neoplasms 3Kidney Neoplasms 2Urologic Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Rectal Neoplasms 1Penile Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Etoposide 30Carboplatin 30Cisplatin 23Ifosfamide 22Filgrastim 22Paclitaxel 18Peripheral Blood Stem Cell Transplantation 16Bleomycin 13Cyclophosphamide 11Radiotherapy 8Thiotepa 7Magnetic Resonance Spectroscopy 6Gemcitabine 6pegfilgrastim 5Therapeutics 5Polymerase Chain Reaction 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Flow Cytometry 5Busulfan 5etoposide phosphate 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Dexamethasone 4sargramostim 3Vinblastine 3Taxes 3Surveys and Questionnaires 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Ultrasonography × Genitourinary × Clear all
NCT05899361 2023-10-24

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Dana-Farber Cancer Institute

Phase NA Recruiting
10 enrolled
Genitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urethral Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡